Decrease in cytochrome c oxidase reserve capacity diminishes robustness of Drosophila melanogaster and shortens

Vladimir Klichko1, Barbara H Sohal2, Svetlana N Radyuk1

  • 1*Department of Biological Sciences, Southern Methodist University, Dallas, TX 75275, U.S.A.

The Biochemical Journal
|January 22, 2014
PubMed

Insights

Suppressing cytochrome c oxidase (CcO) function harms fruitfly survival, contrary to aging theories. Re-engineering CcO activity in vivo shows complex effects on lifespan and fitness.

Area of Science:

  • Mitochondrial biology
  • Aging research
  • Genetics

Background:

  • The hypothesis that suppressing mitochondrial electron-transport chain (ETC) oxidoreductase activity retards aging is widely studied.
  • Cytochrome c oxidase (CcO) is a key enzyme in the mitochondrial ETC, crucial for cellular respiration.
  • Understanding CcO's role in aging requires examining the effects of its regulatory subunits.

Purpose of the Study:

  • To investigate the phenotypic consequences of altering CcO regulatory subunits IV and Vb in Drosophila melanogaster.
  • To test the hypothesis that reduced ETC activity, specifically CcO function, might extend lifespan.
  • To explore the potential for in vivo re-engineering of CcO structure and function.

Main Methods:

  • RNA interference (RNAi) was used to induce underexpression of CcO subunits IV and Vb.
  • Overexpression studies were conducted in both young and old Drosophila.
  • Measurements included mRNA and protein levels, CcO holoenzyme activity, mitochondrial respiration rates, and lifespan.

Main Results:

  • Underexpression of CcO subunits led to decreased mRNA, protein, CcO activity, respiration, walking speed, and lifespan.
  • Overexpression of CcO IV or Vb in young flies increased mRNA but not protein or activity.
  • Overexpression of CcO Vb in older flies increased mRNA, protein, and activity, counteracting age-related decline, but did not alter lifespan.

Conclusions:

  • Suppression of CcO function has detrimental effects on fitness and survival, challenging the proposed benefits of reduced ETC activity.
  • The study demonstrates that CcO, an ETC oxidoreductase, can be functionally modified in vivo.
  • CcO's role in aging is complex, with specific subunit manipulations yielding varied outcomes without lifespan extension.

Related Concept Videos